Literature DB >> 24356932

Novel functional magnetic resonance imaging biomarkers for assessing response to therapy in hepatocellular carcinoma.

Z Yuan1, W-T Li, X-D Ye, H-Y Zhu, W-J Peng.   

Abstract

The established and adapted image biomarkers based on size for tumor burden measurement continue to be applied to hepatocellular carcinoma (HCC) as size measurement can easily be used in clinical practice. However, in the setting of novel targeted therapies and liver directed treatments, simple tumor anatomical changes can be less informative and usually appear later than biological changes. Functional magnetic resonance imaging (MRI) has a potential to be a promising technique for assessment of HCC response to therapy. In this review, we discuss various functional MRI biomarkers that play an increasingly important role in evaluation of HCC response after treatment.

Entities:  

Mesh：

Year:  2013        PMID： 24356932     DOI： 10.1007/s12094-013-1147-5

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


  71 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

2.  Role of diffusion-weighted imaging in evaluating therapeutic efficacy after transcatheter arterial chemoembolization for hepatocellular carcinoma.

Authors:  Kei Kubota; Tomoaki Yamanishi; Satoshi Itoh; Yoriko Murata; Kana Miyatake; Hiroaki Yasunami; Kazuo Morio; Norihiko Hamada; Akihito Nishioka; Yasuhiro Ogawa
Journal:  Oncol Rep       Date:  2010-09       Impact factor: 3.906

3.  Correlation of radiobiological assays of hypoxic fraction with phosphorus-31 magnetic resonance spectroscopy across multiple tumor lines.

Authors:  S J Li; G Y Jin; B L Fish; J E Moulder
Journal:  Radiat Res       Date:  1995-07       Impact factor: 2.841

4.  Quantitative mapping of hepatic perfusion index using MR imaging: a potential reproducible tool for assessing tumour response to treatment with the antiangiogenic compound BIBF 1120, a potent triple angiokinase inhibitor.

Authors:  Keiko Miyazaki; David J Collins; Simon Walker-Samuel; Jane N Taylor; Anwar R Padhani; Martin O Leach; Dow-Mu Koh
Journal:  Eur Radiol       Date:  2008-03-20       Impact factor: 5.315

5.  Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging.

Authors:  J Kurhanewicz; D B Vigneron; H Hricak; F Parivar; S J Nelson; K Shinohara; P R Carroll
Journal:  Radiology       Date:  1996-08       Impact factor: 11.105

6.  Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances.

Authors:  D K Menon; J Sargentoni; S D Taylor-Robinson; J D Bell; I J Cox; D J Bryant; G A Coutts; K Rolles; A K Burroughs; M Y Morgan
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

7.  Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma.

Authors:  Zheng Yuan; Xiao-Dan Ye; Sheng Dong; Li-Chao Xu; Xue-Yuan Xu; Shi-Yuan Liu; Xiang-Sheng Xiao
Journal:  Eur J Radiol       Date:  2009-06-18       Impact factor: 3.528

8.  Hepatocellular adenoma: diagnostic difficulties and novel imaging techniques.

Authors:  A K P Lim; N Patel; W M W Gedroyc; M J K Blomley; G Hamilton; S D Taylor-Robinson
Journal:  Br J Radiol       Date:  2002-08       Impact factor: 3.039

9.  In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver.

Authors:  S D Taylor-Robinson; J Sargentoni; J D Bell; N Saeed; K K Changani; B R Davidson; K Rolles; A K Burroughs; H J Hodgson; C S Foster; I J Cox
Journal:  Liver       Date:  1997-08

10.  Three-dimensional whole-liver perfusion magnetic resonance imaging in patients with hepatocellular carcinomas and colorectal hepatic metastases.

Authors:  Sheng-Xiang Rao; Cai-Zhong Chen; Hao Liu; Meng-Su Zeng; Xu-Dong Qu
Journal:  BMC Gastroenterol       Date:  2013-03-25       Impact factor: 3.067
View more
  3 in total

1.  Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma.

Authors:  Bang-Bin Chen; Chao-Yu Hsu; Chih-Wei Yu; Po-Chin Liang; Chiun Hsu; Chih-Hung Hsu; Ann-Lii Cheng; Tiffany Ting-Fang Shih
Journal:  Eur Radiol       Date:  2016-12-12       Impact factor: 5.315

2.  Histogram analysis of apparent diffusion coefficient predicts response to radiofrequency ablation in hepatocellular carcinoma.

Authors:  Xiaohong Ma; Han Ouyang; Shuang Wang; Meng Wang; Chunwu Zhou; Xinming Zhao
Journal:  Chin J Cancer Res       Date:  2019-04       Impact factor: 5.087

Review 3.  Recent advances in non-invasive magnetic resonance imaging assessment of hepatocellular carcinoma.

Authors:  Davide Ippolito; Riccardo Inchingolo; Luigi Grazioli; Silvia Girolama Drago; Michele Nardella; Marco Gatti; Riccardo Faletti
Journal:  World J Gastroenterol       Date:  2018-06-21       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.